Canton Strategic Holdings, Inc. (CNTN)

Canton Strategic Holdings, Inc. (CNTN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $149M; returns 1 day +0.0%, 1 week +9.7%.

Canton Strategic Holdings Inc. (formerly Tharimmune Inc.) is a clinical-stage biotechnology company that underwent a major corporate rebranding and pivot in February 2026. The company focuses on developing a diversified portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.

Groups CNTN belongs to

• Clinical Stage Biotech
• Biotechnology
• Rare Diseases
• Liver Disease
• Chronic Inflammatory Diseases
• Unmet Medical Needs
• Healthcare
• Oncology
• Life Sciences

CNTN financial model: income statement, cash flow and balance sheet